COMMUNIQUÉS West-GlobeNewswire

Generex Biotechnology Announces the Appointment of Chief Commercial Officer
12/03/2019
Lance Goudzwaard Appointed to Head Commercialization and Customer Relations for NuGenerex Distribution Solutions Subsidiary MIRAMAR, FL, March 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology [...]
Zealand Pharma convenes its Annual General Meeting 2019
12/03/2019
Company Announcement – No. 04/2019 Zealand Pharma convenes its Annual General Meeting 2019 Copenhagen, March 12, 2019 – Zealand Pharma A/S ("Zealand") convenes the Company’s ordinary Annual General Meeting to be held on [...]
Sharps Compliance Appoints Linda Brock as Vice President of Sales
12/03/2019
HOUSTON, March 12, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, [...]
Crown Bioscience Inc. and Charles River Laboratories Enter Agreement to Expand Access to ZDSD Rat Model
12/03/2019
Agreement enables greater global model availability for drug discovery in Obesity, Diabetes and Metabolic Syndrome SAN DIEGO, Calif. and WILMINGTON, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global [...]
HX Global Announces Appointment of Tim Crockett as Senior Vice President, US Business Operations
12/03/2019
BOSTON, March 12, 2019 (GLOBE NEWSWIRE) -- HX Global, the Americas division of Healix International, is pleased to announce the appointment of Tim Crockett as Senior Vice President, US Business Operations. This [...]
Anthogyr rejoint le Groupe Straumann
12/03/2019
Straumann Group augmente sa participation dans le fabricant français d'implants Anthogyr de 30% à 100%. Anthogyr, société privée, fournit au Groupe Straumann une gamme supplémentaire de solutions implantaires de haute [...]
Nexstim Plc is planning a rights issue
12/03/2019
Company Announcement, Helsinki, 12 March 2019 at 2.00 pm (EET) Nexstim Plc is planning a Rights Issue Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering [...]
Forty Seven Inc. to Present at Oppenheimer 29th Annual Healthcare Conference
12/03/2019
MENLO PARK, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Join Achieve TMS East to Celebrate the Grand Opening of its Andover Location
12/03/2019
ANDOVER, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of depression and obsessive-compulsive [...]
Anthogyr joins the Straumann Group
12/03/2019
Straumann Group increases stake in French implant manufacturer Anthogyr from 30% to full ownership Privately-held Anthogyr provides Straumann Group with an additional range of attractively-priced high-quality implant [...]
IBEX Reports Plans to Close Iowa Production Facility
12/03/2019
MONTREAL, March 12, 2019 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported that it plans to close its Iowa production facility as of July 31, 2019. The Iowa [...]
Krystal Biotech Reports 2018 Financial Results and Business Progress
12/03/2019
Topline-data from Phase 1/2 clinical trial of KB103 (bercolagene telserpavec) for treatment dystrophic epidermolysis bullosa (DEB) to be announced in 1H 2019 Ancoris, a cGMP facility for clinical and commercial [...]
Bio-Research Products Reports Plans to Close North Liberty Production Facility
12/03/2019
NORTH LIBERTY, Iowa, March 12, 2019 (GLOBE NEWSWIRE) -- Bio-Research Products Inc. today reported that it plans to close its North Liberty production facility as of July 31, 2019. Bio-Research Products (“BRP”) produces [...]
CymaBay Therapeutics to Present at Upcoming Investor Conferences in March
12/03/2019
NEWARK, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
Synthorx to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
12/03/2019
SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics [...]
Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18
12/03/2019
Findings from first two cohorts show primary safety endpoint met and early signals of efficacy HAIFA, Israel, March 12, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading [...]
Sport Endurance Completes Transition to Better Choice Company and Begins Trading Under the Symbol ‘BTTR’
12/03/2019
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTC QB: SENZ) announced today that it has received final FINRA approval to complete its reincorporation to Better Choice Company, Inc. (the “Company [...]
Cannabis Stocks That Could See Significant Growth in Retail
12/03/2019
VANCOUVER, British Columbia, March 12, 2019 (GLOBE NEWSWIRE) -- Cannabis sales have been soaring since legalization in Canada but there's a lot more to come as the industry continues to change. With more retailers [...]
TG Therapeutics, Inc. Announces Data Presentation at the Upcoming American Academy of Neurology 71st Annual Meeting
12/03/2019
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that data from the Phase 2 multicenter trial evaluating ublituximab (TG-1101), the Company’s novel glycoengineered anti- [...]

Pages